• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • T. Smith, J. Khatcheressian, +19 authors A. Wolff
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2006 (First Publication: 1 July 2006)
  • PURPOSE To update the 2000 American Society of Clinical Oncology guideline on the use of hematopoietic colony-stimulating factors (CSF). UPDATE METHODOLOGY The Update Committee completed a reviewExpand
  • Lee S Schwartzberg, Fernando Rivera, +6 authors William Y. Go
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2014 (First Publication: 20 July 2014)
  • PURPOSE To evaluate panitumumab plus modified fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) or bevacizumab plus mFOLFOX6 in patients with previously untreated wild-type (WT) KRAS exon 2Expand
  • C. Vogel, M. Wojtukiewicz, +5 authors L. Schwartzberg
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2005 (First Publication: 20 February 2005)
  • PURPOSE We evaluated the efficacy of pegfilgrastim to reduce the incidence of febrile neutropenia associated with docetaxel in breast cancer patients. PATIENTS AND METHODS Patients were randomlyExpand
  • H. Hochster, L. Hart, +9 authors E. Hedrick
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2008 (First Publication: 20 July 2008)
  • PURPOSE To evaluate the safety and efficacy of three oxaliplatin and fluoropyrimidine regimens, with or without bevacizumab, as first-line treatment for metastatic colorectal cancer (CRC). PATIENTSExpand
  • Kevin S. Robinson, Michael E. Williams, +6 authors Bruce D Cheson
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2008 (First Publication: 20 September 2008)
  • PURPOSE Bendamustine HCl is a bifunctional mechlorethamine derivative with clinical activity in the treatment of non-Hodgkin's lymphoma. This study evaluated bendamustine plus rituximab in 67 adultsExpand
  • W. Gradishar, B. Anderson, +28 authors Rashmi Kumar
  • Medicine
  • Journal of the National Comprehensive Cancer…
  • 2014 (First Publication: 1 April 2014)
  • Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death. The overall management of breast cancer includes the treatmentExpand
  • Lee S Schwartzberg, Sandra X. Franco, A. Florance, Lisa O’Rourke, Julie Maltzman, Stephen R. D. Johnston
  • Medicine
  • The oncologist
  • 2010 (First Publication: 1 February 2010)
  • Reported are results from a subgroup analysis of postmenopausal women with hormone receptor–positive human epidermal growth factor receptor 2–positive metastatic breast cancer from a phase III trialExpand
  • P. Coluzzi, L. Schwartzberg, J. Conroy, S. Charapata, R. Portenoy
  • Medicine
  • Pain
  • 2001 (First Publication: 1 March 2001)
  • &NA; Oral transmucosal fentanyl citrate (OTFC®; Actiq®) is a drug delivery formulation used for management of breakthrough cancer pain. Previous studies with open‐label comparisons indicated OTFC wasExpand